THE SIGNIFICANCE OF ALK REARRANGEMENT IN SELECTED ADVANCED NON-SMALL CELL LUNG CANCER: ALK EXPRESSION PROVIDES INSIGHTS INTO ALK TARGET THERAPY

被引：0
|
作者：
Zhang, Ningning [1 ,2 ]
Shi, Yuankai [1 ,2 ]
Ma, Li [1 ,2 ]
Hao, Xuezhi [1 ,2 ]
Lin, Dongmei [2 ,3 ]
Han, Xiaohong [1 ,2 ]
Liu, Yutao [1 ,2 ]
Wang, Lin [1 ,2 ]
Yuan, Zheng [2 ,3 ]
Yang, Sheng [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, Canc Inst Hosp, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Canc Inst Hosp, Dept Pathol, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Alk rearrangement; non-small cell lung cancer; ALK expression; Crizotinib;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.11-038
引用
收藏
页码：S612 / S612
页数：1
相关论文
共 50 条
  • [1] The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy
    Zhang, Ning-Ning
    Liu, Yu-Tao
    Ma, Li
    Wang, Lin
    Hao, Xue-Zhi
    Yuan, Zheng
    Lin, Dong-Mei
    Li, Dan
    Zhou, Yu-Jie
    Lin, Hua
    Han, Xiao-Hong
    Sun, Yan
    Shi, Yuankai
    PLOS ONE, 2014, 9 (01):
  • [2] ALK rearrangement in non-small cell lung cancer
    Naulleau, Gaspard
    Birsen, Gary
    Mansuet-Lupo, Audrey
    Leroy, Karen
    Wislez, Marie
    BULLETIN DU CANCER, 2025, 112 (03) : 3S86 - 3S94
  • [3] Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangement
    Fujiwara, Ayako
    Higashiyama, Masahiko
    Kanou, Takashi
    Tokunaga, Toshiteru
    Okami, Jiro
    Kodama, Ken
    Nishino, Kazumi
    Tomita, Yasuhiko
    Okamoto, Isamu
    LUNG CANCER, 2014, 83 (02) : 302 - 304
  • [4] Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer
    Hu, Haoyue
    Tan, Songtao
    Xie, Meng
    Guo, Peng
    Yu, Qiang
    Xiao, Juan
    Zhao, Kangrui
    Liao, Qiong
    Wang, Yi
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [5] Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung Cancer
    Shirish M. Gadgeel
    Current Treatment Options in Oncology, 2017, 18
  • [6] CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer
    Zhang, Meiling
    Wang, Qian
    Ding, Yan
    Wang, Guoqun
    Chu, Yunqian
    He, Xiang
    Wu, Xue
    Shao, Yang W.
    Lu, Kaihua
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1792 - 1797
  • [7] Sequencing of ALK Inhibitors in ALK plus Non-Small Cell Lung Cancer
    Gadgeel, Shirish M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (06)
  • [8] Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina
    Verzura, Maria
    Batagelj, Emilio
    Bagnes, Claudia
    Martin, Claudio
    Enrico, Diego
    Richardet, Eduardo
    De la Iglesia, Paola
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 : 77 - 81
  • [9] Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small Cell Lung Cancer with ALK Rearrangement
    Zhang, Chao
    Li, Shao-lei
    Nie, Qiang
    Dong, Song
    Shao, Yang
    Yang, Xue-ning
    Wu, Yi-long
    Yang, Yue
    Zhong, Wen-zhao
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) : 726 - 731
  • [10] ALK inhibitors and advanced non-small cell lung cancer (Review)
    Rossi, Antonio
    Maione, Paolo
    Sacco, Paola Claudia
    Sgambato, Assunta
    Casaluce, Francesca
    Ferrara, Marianna Luciana
    Palazzolo, Giovanni
    Ciardiello, Fortunato
    Gridelli, Cesare
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 499 - 508
12345